EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC 4.0

Development and validation of a nomogram model for predicting diabetic foot in type 2 diabetes

Chuanqing Xie, Ya Li

PeerJ · 21.07.2026 · 14 · e21584

DOI: 10.7717/peerj.21584 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift PeerJ, online erschienen am 21.07.2026. Verfasst von Chuanqing Xie und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The First Affiliated Hospital of Xi'an Medical University, Xi'an Medical University, Xi'an, Shanxi, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Nomograms, Diabetic Foot. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic foot (DF) represents a serious complication associated with type 2 diabetes mellitus (T2DM), characterized by elevated rates of morbidity and mortality, alongside substantial healthcare expenditures. Early detection and intervention are essential for enhancing patient prognosis. The objective of this research is to establish a nomogram model for predicting diabetic foot (DF) risk in type 2 diabetes (T2DM).

Methods

We conducted a retrospective analysis of 450 individuals with T2DM. Patients were divided into training and validation sets in a 7:3 ratio randomly. We utilized the least absolute shrinkage and selection operator (LASSO) regression, followed by multivariable logistic regression to determine independent risk factors. The performance of the nomogram was evaluated through receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA).

Results

Six independent factors were incorporated into the nomogram: diabetic peripheral neuropathy (DPN), coronary heart disease (CHD), serum albumin (ALB) levels, high-density lipoprotein cholesterol levels (HDLC), fasting blood glucose levels (FBG), and the neutrophil percentage-to-hemoglobin ratio (NPHR). This model demonstrated impressive discrimination, achieving an area under the curve (AUC) of 0.945 (95% confidence interval (CI) [0.9226–0.968]) in the training cohort and 0.941 (95% CI [0.9021–0.9789]) in the validation cohort, while the calibration curves illustrated a positive alignment between predictions and the observed data. Additionally, the DCA revealed clinical benefits.

Conclusion

This nomogram enables individualized risk stratification, guiding clinicians to prioritize high-risk patients for preventive care, thereby reducing diabetes-related complications and optimizing resource utilization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2NomogramsDiabetic FootHumansFemaleRetrospective StudiesMaleMiddle AgedRisk FactorsROC CurveAgedBlood GlucoseRisk AssessmentDiabetic NeuropathiesLogistic Models

Stichwörter der Autor:innen

Diabetic footNomogramPredictive modelRisk stratificationType 2 diabetes

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Department of Endocrinology, The First Affiliated Hospital of Xi'an Medical University, Xi'an Medical University, Xi'an, Shanxi, China.

Zitieren

APA

Xie, C., & Li, Y. (2026). Development and validation of a nomogram model for predicting diabetic foot in type 2 diabetes. PeerJ, 14, e21584. https://doi.org/10.7717/peerj.21584

Vancouver

Xie C, Li Y. Development and validation of a nomogram model for predicting diabetic foot in type 2 diabetes. PeerJ. 2026;14:e21584. doi:10.7717/peerj.21584

BibTeX
@article{Xie2026,
  author = {Xie, Chuanqing and Li, Ya},
  title = {Development and validation of a nomogram model for predicting diabetic foot in type 2 diabetes},
  journal = {PeerJ},
  year = {2026},
  volume = {14},
  pages = {e21584},
  doi = {10.7717/peerj.21584}
}
Kostenlos starten →